AstraZeneca Can't Prevent FDA Approval Of Generic Seroquel

Law360, New York (March 23, 2012, 8:20 PM EDT) -- A Washington federal judge on Friday tossed AstraZeneca PLC's suit seeking to delay the launch of generic versions of its blockbuster anti-psychotic drug Seroquel with labels that omit hyperglycemia warnings AstraZeneca was required to add, finding the drugmaker's claim was not yet ripe for review.

U.S. District Judge Colleen Kollar-Kotelly also denied AstraZeneca's bid for a preliminary injunction to stop the U.S. Food and Drug Administration from giving final approval to a generic version of Seroquel, finding the company had failed to show it was entitled...
To view the full article, register now.